AA
CL icon

ALPS Advisors’s Colgate-Palmolive CL Stock Holding History

ALPS Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.87M Sell
33,703
-7,937
-19% -$707K 0.01% 340
2025
Q4 		$3.29M Sell
41,640
-173
-0.4% -$13.6K 0.02% 313
2025
Q3 		$3.34M Buy
41,813
+8,238
+25% +$703K 0.02% 304
2025
Q2 		$3.05M Sell
33,575
-98
-0.3% -$8.95K 0.02% 302
2025
Q1 		$3.16M Buy
33,673
+899
+3% +$80.5K 0.02% 288
2024
Q4 		$2.98M Sell
32,774
-98
-0.3% -$9.35K 0.02% 289
2024
Q3 		$3.41M Buy
32,872
+4,723
+17% +$481K 0.02% 282
2024
Q2 		$2.73M Sell
28,149
-17
-0.1% -$1.57K 0.02% 297
2024
Q1 		$2.54M Buy
28,166
+4,260
+18% +$361K 0.02% 316
2023
Q4 		$1.91M Buy
23,906
+120
+0.5% +$9.02K 0.02% 336
2023
Q3 		$1.69M Sell
23,786
-9,684
-29% -$724K 0.01% 346
2023
Q2 		$2.58M Sell
33,470
-842
-2% -$65.2K 0.02% 269
2023
Q1 		$2.58M Sell
34,312
-18,536
-35% -$1.38M 0.02% 248
2022
Q4 		$4.16M Sell
52,848
-5,255
-9% -$394K 0.04% 190
2022
Q3 		$4.08M Sell
58,103
-58,380
-50% -$4.58M 0.04% 192
2022
Q2 		$9.34M Buy
116,483
+95,569
+457% +$7.47M 0.09% 149
2022
Q1 		$1.59M Sell
20,914
-3,187
-13% -$252K 0.02% 269
2021
Q4 		$2.06M Sell
24,101
-3,122
-11% -$244K 0.02% 287
2021
Q3 		$2.06M Sell
27,223
-5,591
-17% -$444K 0.02% 314
2021
Q2 		$2.67M Sell
32,814
-1,370
-4% -$112K 0.02% 245
2021
Q1 		$2.69M Sell
34,184
-3,937
-10% -$309K 0.03% 229
2020
Q4 		$3.26M Sell
38,121
-2,526
-6% -$209K 0.04% 207
2020
Q3 		$3.14M Sell
40,647
-3,323
-8% -$253K 0.05% 189
2020
Q2 		$3.22M Buy
43,970
+7,663
+21% +$544K 0.04% 189
2020
Q1 		$2.41M Buy
36,307
+26,059
+254% +$1.84M 0.04% 193
2019
Q4 		$705K Sell
10,248
-724
-7% -$49.4K 0.01% 461
2019
Q3 		$807K Sell
10,972
-4,152
-27% -$301K 0.01% 343
2019
Q2 		$1.08M Sell
15,124
-960
-6% -$68.1K 0.01% 313
2019
Q1 		$1.1M Buy
+16,084
New +$1.04M 0.01% 305

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ALPS Advisors's CL Position: Q1 2026 in Review

ALPS Advisors reduced its Colgate-Palmolive (CL) stake by 19% in Q1 2026, selling an estimated $707K and leaving 33,703 shares worth $2.87M. The position accounts for 0.01% of the portfolio, ranked #340.

ALPS Advisors first reported a position in CL in Q1 2019 and has held it in 29 quarters since. The position peaked at $9.34M in Q2 2022. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • ALPS Advisors held 33,703 shares of Colgate-Palmolive worth $2.87M as of Q1 2026.
  • ALPS Advisors sold 7,937 Colgate-Palmolive shares in Q1 2026, an estimated $707K.
  • Colgate-Palmolive made up 0.01% of ALPS Advisors's portfolio in Q1 2026, its #340 holding.
  • ALPS Advisors first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 29 quarters since.
  • ALPS Advisors's Colgate-Palmolive position peaked at $9.34M in Q2 2022.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.